Backed by former Google CEO’s VC, a Colorado biotech hatches platform to evolve degraders
View More News
Backed by former Google CEO’s VC, a Colorado biotech hatches platform to evolve degraders
BioLoomics’ goal is to make a degrader from an antibody in one month
September 26, 2023
BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies
Our mission is to make safer, more effective cancer therapeutics.
September 25, 2023
Pre-Seed Extension
BioLoomics closed a $575,000 round of pre seed extension funding on May 11, 2021..
September 25, 2023
OEDIT Grant Award
The Colorado OEDIT provides funding opportunities to small businesses in fourteen industries...
September 26, 2023
BioLoomics Closes $600k Pre-Seed Round to Launch Biosensing Drug Discovery Platform
We are excited to announce that on May 30, 2019, BioLoomics closed a $600,000 pre-seed round...
September 25, 2023
